市場調査レポート

商品コード

1458109

羊膜の世界市場規模、シェア、成長分析、製品別、用途別-産業予測、2024～2031年

Global Amniotic Membrane Market Size, Share, Growth Analysis, By Product(Cryopreserved, and Dehydrated), By Application(Surgical Wounds, Ophthalmology) - Industry Forecast 2024-2031

出版日: 2024年03月25日 | 発行: SkyQuest

| ページ情報: 英文 219 Pages | 納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 842,541円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 985,614円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,128,687円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=158.97円

全表示
概要
目次

概要

サンプル依頼リストに入れる

羊膜の世界市場規模は2022年に34億2,000万米ドルと評価され、2023年の39億米ドルから2031年には111億2,000万米ドルに成長し、予測期間中（2024～2031年）のCAGRは14％で成長する展望です。

眼科疾患、創傷治癒、組織再生に効率的な治療を提供することが羊膜市場の目的です。糖尿病性足潰瘍や静脈性下腿潰瘍のような長期的な創傷のための生物学的足場やドレッシングは、羊膜から作ることができます。市場の主要原動力は、眼病や慢性創傷の発生率の上昇です。糖尿病や加齢黄斑変性症を含む疾患の有病率の上昇により、高度な創傷治療や眼科治療に対するニーズが著しく高まっています。羊膜市場は成長しているが、それを制限しているいくつかの障害があります。特定のセグメントでは、ヒト由来の組織を使用することは倫理的・規制的制約から困難が伴う。また、品質管理や製品の均一性にも問題があります。羊膜の治療効果は、羊膜の完全性と生命力が、製造から流通に至るまで維持されているかどうかにかかっています。世界の羊膜市場の目標は、目の治療と創傷治癒のための効率的なソリューションを提供することです。目の病気や慢性創傷の発生率の増加が市場を牽引しています。しかし、複雑な規制、高額な費用、品質管理の難しさが阻害要因となっています。しかし、技術開拓と再生医療への注目の高まりは、市場拡大の展望を示しています。

技術分析
価格分析
サプライチェーン分析
バリューチェーン分析
市場のエコシステム
IP分析
貿易分析
スタートアップ分析
原材料の分析
イノベーションマトリクス
パイプライン製品の分析
マクロ経済指標
主要投資の分析
主要成功要因
競合の程度

市場力学と展望

市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
規制情勢
ポーターの分析
将来の混乱についての特別な考察

羊膜の世界市場：製品別

市場概要
冷凍保存
脱水症状

羊膜の世界市場：用途別

市場概要
手術の傷
眼科
その他

羊膜の世界市場規模：地域別

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
ラテンアメリカ
- ブラジル
- その他のラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2021年）
主要市場企業が採用した戦略
主要成功戦略
市場における最近の活動
主要企業の市場シェア（2021年）

主要企業プロファイル

MiMedx Group, Inc.（米国）
TissueTech, Inc.（米国）
Skye Biologics, Inc.（米国）
Alliqua BioMedical, Inc.（米国）
Amnio Technology, LLC（米国）
Katena Products, Inc.（米国）
Applied Biologics LLC（米国）
Amniox Medical, Inc.（米国）
Derma Sciences, Inc.（米国）
Organogenesis Holdings Inc.（米国）
Smith & Nephew plc（英国）
Integra LifeSciences Corporation（米国）
Osiris Therapeutics, Inc.（米国）
AmnioLife Corporation（米国）
Human Regenerative Technologies, LLC（米国）
AlloSource（米国）
LifeCell International Pvt. Ltd.（インド）
Amnion Life（米国）
Surgenex（米国）
NuVision Biotherapies Ltd.（英国）

Product Code: SQMIG35H2086

Global Amniotic Membrane Market size was valued at USD 3.42 billion in 2022 and is poised to grow from USD 3.90 billion in 2023 to USD 11.12 billion by 2031, growing at a CAGR of 14% during the forecast period (2024-2031).

Providing efficient treatments for ophthalmic problems, wound healing, and tissue regeneration is the aim of the amniotic membrane market. A biological scaffold or dressing for long-term wounds, like diabetic foot ulcers and venous leg ulcers, can be made from the amniotic membrane. The market is primarily driven by the rising incidence of eye illnesses and chronic wounds. The need for sophisticated wound care and ocular treatments has increased significantly due to the rising prevalence of diseases including diabetes and age-related macular degeneration. The market for amniotic membranes is growing, however there are several obstacles that are limiting it. In certain areas, using tissues originating from humans presents difficulties due to ethical and regulatory constraints. The market also has issues with quality control and product uniformity. The therapeutic efficacy of amniotic membranes depends on their integrity and vitality being maintained throughout the production and distribution procedures. The goal of the worldwide amniotic membrane market is to supply efficient solutions for eye therapy and wound healing. The growing incidence of eye illnesses and chronic wounds is driving the market. Restraints, however, come from complicated regulations, expensive expenses, and difficulties with quality control. However, technological developments and an increasing focus on regenerative medicine present prospects for market increase.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Amniotic Membrane Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Amniotic Membrane Market Segmental Analysis

The product, application, and geographic segments of the worldwide amniotic membrane market are divided up. The market is divided into dehydrated and cryopreserved segments based on the product. The market is divided into surgical wounds, ophthalmology, and other segments based on application. The market is divided into Latin America, Middle East and Africa, Asia Pacific, North America, and Europe.

Drivers of the Global Amniotic Membrane Market

One major factor driving the amniotic membrane market is the rising prevalence of chronic wounds, such as diabetic foot ulcers and venous leg ulcers. Amniotic membranes have demonstrated encouraging outcomes in aiding healing and tissue regeneration, which is why these conditions demand efficient wound healing therapies.

Restraints in the Global Amniotic Membrane Market

In certain areas, the use of tissues derived from humans, such amniotic membranes, presents ethical and regulatory challenges. Tight laws governing the acquisition, processing, and safety of tissue might present problems for industry participants, restricting their capacity to supply goods in specific areas.

Market Trends of the Global Amniotic Membrane Market

Originally, amniotic membranes were applied to wound healing. But there's a rising movement to investigate their possibilities in other therapeutic domains, such orthopedics, dentistry, and ophthalmology. Amniotic membrane-based medicines are becoming more widely used, and researchers and businesses are looking into additional indications.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Amniotic Membrane Market by Product

Market Overview
Cryopreserved
and Dehydrated

Global Amniotic Membrane Market by Application

Market Overview
Surgical Wounds
Ophthalmology
and Others

Global Amniotic Membrane Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

MiMedx Group, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TissueTech, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Skye Biologics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alliqua BioMedical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amnio Technology, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Katena Products, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Applied Biologics LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amniox Medical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Derma Sciences, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Organogenesis Holdings Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith & Nephew plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integra LifeSciences Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Osiris Therapeutics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AmnioLife Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Human Regenerative Technologies, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AlloSource (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LifeCell International Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amnion Life (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Surgenex (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NuVision Biotherapies Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments